XML 55 R45.htm IDEA: XBRL DOCUMENT v3.24.3
Segment Reporting - Income Statements (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Sep. 30, 2024
Sep. 30, 2023
Revenues:                
Total revenues $ 373,640     $ 356,524     $ 1,115,808 $ 1,048,773
Expenses:                
Property operating expenses 309,697     298,432     921,366 870,740
Depreciation and amortization 68,959     67,236     207,449 200,430
General and administrative 13,933     6,954     27,763 20,111
Acquisition and certain other transaction related costs 331     3,676     2,243 9,812
Impairment of assets 23,031     1,156     41,718 18,380
Total expenses 415,951     377,454     1,200,539 1,119,473
Gain (loss) on sale of properties 111     0     (18,976) 1,233
Gains on equity securities, net 0     0     0 8,126
Interest and other income 2,575     3,243     7,215 12,572
Interest expense (59,443)     (47,758)     (175,721) (142,922)
Loss on modification or early extinguishment of debt 0     0     (209) (1,075)
Loss before income tax expense and equity in net earnings (losses) of investees (99,068)     (65,445)     (272,422) (192,766)
Income tax expense (148)     (189)     (505) (379)
Equity in net earnings (losses) of investees 527     (145)     (9,882) 2,137
Net loss (98,689) $ (97,861) $ (86,259) (65,779) $ (72,571) $ (52,658) (282,809) (191,008)
Rental income                
Revenues:                
Total revenues 61,635     63,390     187,155 191,201
Residents fees and services                
Revenues:                
Total revenues 312,005     293,134     928,653 857,572
Operating Segments | Medical Office and Life Science Portfolio                
Revenues:                
Total revenues 52,901     55,058     161,605 165,448
Expenses:                
Property operating expenses 25,074     25,784     73,253 73,237
Depreciation and amortization 18,773     20,175     58,488 63,065
General and administrative 0     0     0 0
Acquisition and certain other transaction related costs 0     0     0 0
Impairment of assets 23,031     427     41,718 14,034
Total expenses 66,878     46,386     173,459 150,336
Gain (loss) on sale of properties 111           (18,976) 0
Gains on equity securities, net               0
Interest and other income 0     0     0 0
Interest expense (2,319)     (119)     (3,435) (344)
Loss on modification or early extinguishment of debt             0 0
Loss before income tax expense and equity in net earnings (losses) of investees (16,185)     8,553     (34,265) 14,768
Income tax expense 0     0     0 0
Equity in net earnings (losses) of investees 1,707     (145)     (18,173) 2,137
Net loss (14,478)     8,408     (52,438) 16,905
Operating Segments | SHOP                
Revenues:                
Total revenues 312,005     293,134     928,653 857,572
Expenses:                
Property operating expenses 284,572     272,445     847,526 796,733
Depreciation and amortization 47,343     44,587     141,176 129,891
General and administrative 0     0     0 0
Acquisition and certain other transaction related costs 0     0     0 0
Impairment of assets 0     729     0 4,346
Total expenses 331,915     317,761     988,702 930,970
Gain (loss) on sale of properties 0           0 1,233
Gains on equity securities, net               0
Interest and other income 0     115     0 1,581
Interest expense (54)     (79)     (183) (502)
Loss on modification or early extinguishment of debt             0 0
Loss before income tax expense and equity in net earnings (losses) of investees (19,964)     (24,591)     (60,232) (71,086)
Income tax expense 0     0     0 0
Equity in net earnings (losses) of investees 0     0     0 0
Net loss (19,964)     (24,591)     (60,232) (71,086)
Operating Segments | Rental income | Medical Office and Life Science Portfolio                
Revenues:                
Total revenues 52,901     55,058     161,605 165,448
Operating Segments | Rental income | SHOP                
Revenues:                
Total revenues 0     0     0 0
Operating Segments | Residents fees and services | Medical Office and Life Science Portfolio                
Revenues:                
Total revenues 0     0     0 0
Operating Segments | Residents fees and services | SHOP                
Revenues:                
Total revenues 312,005     293,134     928,653 857,572
Non-Segment                
Revenues:                
Total revenues 8,734     8,332     25,550 25,753
Expenses:                
Property operating expenses 51     203     587 770
Depreciation and amortization 2,843     2,474     7,785 7,474
General and administrative 13,933     6,954     27,763 20,111
Acquisition and certain other transaction related costs 331     3,676     2,243 9,812
Impairment of assets 0     0     0 0
Total expenses 17,158     13,307     38,378 38,167
Gain (loss) on sale of properties 0           0 0
Gains on equity securities, net               8,126
Interest and other income 2,575     3,128     7,215 10,991
Interest expense (57,070)     (47,560)     (172,103) (142,076)
Loss on modification or early extinguishment of debt             (209) (1,075)
Loss before income tax expense and equity in net earnings (losses) of investees (62,919)     (49,407)     (177,925) (136,448)
Income tax expense (148)     (189)     (505) (379)
Equity in net earnings (losses) of investees (1,180)     0     8,291 0
Net loss (64,247)     (49,596)     (170,139) (136,827)
Non-Segment | Rental income                
Revenues:                
Total revenues 8,734     8,332     25,550 25,753
Non-Segment | Residents fees and services                
Revenues:                
Total revenues $ 0     $ 0     $ 0 $ 0